drugset / Trial / NCT00691158
A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide
RandomizedCrossoverTriple-blindBasic science
Summary
The purpose of this study is to identify how certain parts of the brain that help control body weight respond to an infusion of hormones called leptin and amylin.
Timeline
- Start
- 2006-01
- Primary completion
- 2024-07
- Completion
- 2024-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metreleptin | Protein / enzyme biologic | 0.06 mg/kg | Intravenous |
| Comparator | Pramlintide | Peptide | 15 ug/ml | Intravenous |
| Comparator | Pramlintide | Peptide | 4.7 ml | Intravenous |